Primary information |
---|
CancerPPD ID | 2867 |
PMID | 22084165 |
YEAR | 2011 |
SEQUENCE | KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK |
LENGTH | 33 |
NAME | IL-4RaÐlytic hybrid peptide |
C-ter Modification | Free |
N-ter Modification | Free |
Linear/Cyclic | Linear |
L/D/Mix | Mix |
Non-Natural | None |
NATURE | Anticancer |
ACTIVITY | IC50=3.6 µMol/L |
SOURCE | Interleukin-4 receptor a (IL-4Ra) chain |
Cancer Type | Lung Cancer |
ASSAY | WST-1 assay |
Patent ID | None |
Tissue | Lung |
CELL LINE | H-322 |
TEST TIME | 24-h |
Secondary information |
---|
STRUCTURE | |
DSSP states | CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC |
SMILES | N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O |
External Links |
---|
PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
NA | NA | NA | NA | NA | NA | NA | NA |
|